Trial Profile
A Randomized Controlled Trial of the Effect of Seasonal Influenza Vaccination on the Incidence of Infection Due to the 2009 H1N1 Influenza.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Sep 2023
Price :
$35
*
At a glance
- Drugs GSK 1536489A (Primary)
- Indications Influenza A virus H1N1 subtype
- Focus Therapeutic Use
- 14 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 13 Jul 2010 Actual end date (Jul 2010) added as reported by ClinicalTrials.gov.
- 13 Jul 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.